Autologous c-Kit+ Mesenchymal Stem Cell Injections Provide Superior Therapeutic Benefit as Compared to c-Kit+ Cardiac-Derived Stem Cells in a Feline Model of Isoproterenol-Induced Cardiomyopathy-Reference-Cited by-同舟云学术

Autologous c-Kit+ Mesenchymal Stem Cell Injections Provide Superior Therapeutic Benefit as Compared to c-Kit+ Cardiac-Derived Stem Cells in a Feline Model of Isoproterenol-Induced Cardiomyopathy

Published:2015-02-11 Issue:5 Volume:8 Page:425-431
ISSN:1752-8054
Container-title:Clinical and Translational Science
language:en
Short-container-title:Clinical And Translational Science

Author:

Taghavi Sharven¹²,Sharp Thomas E.²,Duran Jason M.²,Makarewich Catherine A.²,Berretta Remus M.²,Starosta Tim²,Kubo Hajime²,Barbe Mary³,Houser Steven R.²

Affiliation:

1. Temple University Hospital, Department of Surgery; Philadelphia Pennsylvania USA

2. Temple University School of Medicine, Cardiovascular Research Center; Philadelphia Pennsylvania USA

3. Temple University School of Medicine; Philadelphia Pennsylvania USA

Funder

National Institutes of Health

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

Reference58 articles.

1. Development and proliferative capacity of cardiac muscle cells;Zak;Circ Res.,1974

2. Survey of studies examining mammalian cardiomyocyte DNA synthesis;Soonpaa;Circ Res.,1998

3. Repair of the injured adult heart involves new myocytes potentially derived from resident cardiac stem cells;Angert;Circ Res.,2011

4. Ventricular myocytes are not terminally differentiated in the adult mammalian heart;Anversa;Circ Res.,1998

5. Adult cardiac stem cells are multipotent and support myocardial regeneration;Beltrami;Cell.,2003

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Scoping review of the use of mesenchymal stem and stromal cell products in cats, Part 1: current logistics and safety;Journal of the American Veterinary Medical Association;2024-04-06

2. Scoping review of the use of mesenchymal stem and stromal cell products in cats, Part 2: current scope and efficacy;Journal of the American Veterinary Medical Association;2024-04-05

3. c-kit+VEGFR-2+ Mesenchymal Stem Cells Differentiate into Cardiovascular Cells and Repair Infarcted Myocardium after Transplantation;Stem Cell Reviews and Reports;2022-08-13

4. CREB1 transcription-activated lncRNA PVT1 promotes cardiac fibrosis via miR-145/HCN1 axis;International Journal of Cardiology;2022-04

5. Mesenchymal Stem Cells Therapeutic Applications in Cardiovascular Disorders;Therapeutic Applications of Mesenchymal Stem Cells in Veterinary Medicine;2022